Filing Details

Accession Number:
0001209191-17-057698
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-10-23 08:08:22
Reporting Period:
2017-10-18
Accepted Time:
2017-10-23 08:08:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1539029 Clearside Biomedical Inc. CLSD Pharmaceutical Preparations (2834) 452437375
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1664697 H. Daniel White C/O Clearside Biomedical, Inc.
900 North Point Parkway, Suite 200
Alpharetta GA 30005
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2017-10-18 3,600 $7.82 477,935 No 4 S Direct
Common Stock Disposition 2017-10-19 3,600 $7.81 474,335 No 4 S Direct
Common Stock Disposition 2017-10-18 400 $7.82 35,709 No 4 S Indirect By White Family Trust
Common Stock Disposition 2017-10-19 400 $7.81 35,309 No 4 S Indirect By White Family Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Indirect By White Family Trust
No 4 S Indirect By White Family Trust
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 301 Indirect As UTMA custodian for son
Common Stock 844 Indirect As UTMA custodian for son
Common Stock 1,188 Indirect As UTMA custodian for son
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the record holders of the securities on March 16, 2017.
  2. This transaction was executed in multiple trades at prices ranging from $7.71 to $7.92, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
  3. This transaction was executed in multiple trades at prices ranging from $7.68 to $7.93, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
  4. These securities are held in trust for the benefit of the reporting person's children. The reporting person's wife serves as trustee of the trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
  5. These securities are held for the benefit of the reporting person's son under the Georgia Uniform Transfers to Minors Act, for which the reporting person serves as custodian. The reporting person disclaims beneficial ownership of these shares, and this report shall not be deemed an admission that the reporting person is the beneficial owner of these shares for purposes of Section 16 or for any other purpose.